Prospects and applicability of molecular diagnosis of allograft rejection

Terry B. Strom, Manikkam Suthanthiran

Research output: Contribution to journalReview article

37 Citations (Scopus)

Abstract

We believe that changes in blood urea nitrogen and plasma creatinine are, at best, surrogate markers for rejection. It seems certain that rejection, an immunologic process must precede deterioration in renal function. We suggest that the efforts to prevent chronic rejection should include an effective means to diagnose rejection before the advent of fixed renal injury. Through an analysis of transcription for a series of genes that are expressed by activated, but not resting, cytotoxic lymphocytes, eg, granzyme B, a remarkably accurate tool for assessing the presence of rejection has emerged. Although our methods first centered on analysis of kidney transplant biopsy specimens, noninvasive surveillance using transcriptional profiling analysis circulating blood or urine sediment cells has proven equally informative. Copyright (C) 2000 by W.B. Saunders Company.

Original languageEnglish
Pages (from-to)103-107
Number of pages5
JournalSeminars in Nephrology
Volume20
Issue number2
Publication statusPublished - 30 Mar 2000
Externally publishedYes

Fingerprint

Allografts
Kidney
Granzymes
Blood Urea Nitrogen
Creatinine
Biomarkers
Urine
Lymphocytes
Transplants
Biopsy
Wounds and Injuries
Genes

ASJC Scopus subject areas

  • Nephrology

Cite this

Prospects and applicability of molecular diagnosis of allograft rejection. / Strom, Terry B.; Suthanthiran, Manikkam.

In: Seminars in Nephrology, Vol. 20, No. 2, 30.03.2000, p. 103-107.

Research output: Contribution to journalReview article

@article{b37949a85cda4f0e82fa7b066264d29c,
title = "Prospects and applicability of molecular diagnosis of allograft rejection",
abstract = "We believe that changes in blood urea nitrogen and plasma creatinine are, at best, surrogate markers for rejection. It seems certain that rejection, an immunologic process must precede deterioration in renal function. We suggest that the efforts to prevent chronic rejection should include an effective means to diagnose rejection before the advent of fixed renal injury. Through an analysis of transcription for a series of genes that are expressed by activated, but not resting, cytotoxic lymphocytes, eg, granzyme B, a remarkably accurate tool for assessing the presence of rejection has emerged. Although our methods first centered on analysis of kidney transplant biopsy specimens, noninvasive surveillance using transcriptional profiling analysis circulating blood or urine sediment cells has proven equally informative. Copyright (C) 2000 by W.B. Saunders Company.",
author = "Strom, {Terry B.} and Manikkam Suthanthiran",
year = "2000",
month = "3",
day = "30",
language = "English",
volume = "20",
pages = "103--107",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Prospects and applicability of molecular diagnosis of allograft rejection

AU - Strom, Terry B.

AU - Suthanthiran, Manikkam

PY - 2000/3/30

Y1 - 2000/3/30

N2 - We believe that changes in blood urea nitrogen and plasma creatinine are, at best, surrogate markers for rejection. It seems certain that rejection, an immunologic process must precede deterioration in renal function. We suggest that the efforts to prevent chronic rejection should include an effective means to diagnose rejection before the advent of fixed renal injury. Through an analysis of transcription for a series of genes that are expressed by activated, but not resting, cytotoxic lymphocytes, eg, granzyme B, a remarkably accurate tool for assessing the presence of rejection has emerged. Although our methods first centered on analysis of kidney transplant biopsy specimens, noninvasive surveillance using transcriptional profiling analysis circulating blood or urine sediment cells has proven equally informative. Copyright (C) 2000 by W.B. Saunders Company.

AB - We believe that changes in blood urea nitrogen and plasma creatinine are, at best, surrogate markers for rejection. It seems certain that rejection, an immunologic process must precede deterioration in renal function. We suggest that the efforts to prevent chronic rejection should include an effective means to diagnose rejection before the advent of fixed renal injury. Through an analysis of transcription for a series of genes that are expressed by activated, but not resting, cytotoxic lymphocytes, eg, granzyme B, a remarkably accurate tool for assessing the presence of rejection has emerged. Although our methods first centered on analysis of kidney transplant biopsy specimens, noninvasive surveillance using transcriptional profiling analysis circulating blood or urine sediment cells has proven equally informative. Copyright (C) 2000 by W.B. Saunders Company.

UR - http://www.scopus.com/inward/record.url?scp=0034103626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034103626&partnerID=8YFLogxK

M3 - Review article

C2 - 10746854

AN - SCOPUS:0034103626

VL - 20

SP - 103

EP - 107

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 2

ER -